PROTRIPTYLINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Protriptyline Hydrochloride, and what generic alternatives are available?
Protriptyline Hydrochloride is a drug marketed by Epic Pharma Llc, Hikma, and Sigmapharm Labs Llc. and is included in three NDAs.
The generic ingredient in PROTRIPTYLINE HYDROCHLORIDE is protriptyline hydrochloride. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the protriptyline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Protriptyline Hydrochloride
A generic version of PROTRIPTYLINE HYDROCHLORIDE was approved as protriptyline hydrochloride by HIKMA on September 16th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROTRIPTYLINE HYDROCHLORIDE?
- What are the global sales for PROTRIPTYLINE HYDROCHLORIDE?
- What is Average Wholesale Price for PROTRIPTYLINE HYDROCHLORIDE?
Summary for PROTRIPTYLINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 58 |
Clinical Trials: | 2 |
Patent Applications: | 699 |
DailyMed Link: | PROTRIPTYLINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for PROTRIPTYLINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Federal University of São Paulo | Phase 4 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Roxane Laboratories | N/A |
Pharmacology for PROTRIPTYLINE HYDROCHLORIDE
Drug Class | Tricyclic Antidepressant |